The downgrade was driven by operating challenges Allina has faced over the last two years coupled with balance sheet metrics that are more in line with the “A+” rating, according to Fitch.
Allina Health reported a $352.6 million operating loss (-6.8% margin) in 2023, an 80% drop from the $195.8 million loss (-3.4% margin) reported in 2022. However, strategic cost reductions and growth led to a $1.9 million operating income before restructuring and strike expenses in the fourth quarter — the first quarter Allinia reported a positive operating income in more than two years, according to financial documents published Feb. 14.
The health system continues to address the rise in its expense base and was able to stem a much larger operational loss in fiscal 2023, than if no initiatives were implemented.
Fitch expects Allina’s operational improvement to continue over the outlook period and balance sheet metrics to improve over a longer period.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
